awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47552083-58EE43A8-F9EE-4C03-B50B-B63D9D7C4230
Q47552083-58EE43A8-F9EE-4C03-B50B-B63D9D7C4230
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47552083-58EE43A8-F9EE-4C03-B50B-B63D9D7C4230
Treatment-free interval as a metric of patient experience and a health outcome of value for advanced multiple myeloma: the case for the histone deacetylase inhibitor panobinostat, a next-generation novel agent.
P2860
Q47552083-58EE43A8-F9EE-4C03-B50B-B63D9D7C4230
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47552083-58EE43A8-F9EE-4C03-B50B-B63D9D7C4230
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9513f9a8c70b0bed063014ff95f5395ed6c0e08b
P2860
Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide.